Cargando…
Enhanced in vivo anti-tumor efficacy of whole tumor lysate in combination with whole tumor cell-specific polyclonal antibody
BACKGROUND AND PURPOSE: Despite the widespread utilization of cancer vaccines with specified antigens, the use of whole tumor cell lysates in tumor immunotherapy would be a very promising approach that can overcome several significant obstacles in vaccine production. Whole tumor cells provide a broa...
Autores principales: | Rahimmanesh, Ilnaz, Esmaili, Yasaman, Ghafouri, Elham, Hejazi, Seyed Hossein, Khanahmad, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976059/ https://www.ncbi.nlm.nih.gov/pubmed/36873278 http://dx.doi.org/10.4103/1735-5362.367793 |
Ejemplares similares
-
Chimeric antigen receptor-T cells immunotherapy for targeting breast cancer
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2021) -
Identification of Significant Genes and Pathways Associated with Tenascin-C in Cancer Progression by Bioinformatics Analysis
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2022) -
The challenging nature of primary T lymphocytes for transfection: Effect of protamine sulfate on the transfection efficiency of chemical transfection reagents
por: Rahimmanesh, Ilnaz, et al.
Publicado: (2020) -
Phage based vaccine: A novel strategy in prevention and treatment
por: Mohammad Hasani, Sharareh, et al.
Publicado: (2023) -
Producing Soluble Human Programmed Cell Death Protein-1: A Natural Supporter for CD4+T Cell Cytotoxicity and Tumor Cells Apoptosis
por: Mohammadzadeh, Samane, et al.
Publicado: (2019)